《Dermatology And Therapy》重点专注发布Medicine-Dermatology领域的新研究，旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。该杂志创刊至今，在Medicine-Dermatology领域，有较高影响力，对来稿文章质量要求较高，稿件投稿过审难度较大。欢迎广大同领域研究者投稿该杂志。
| CiteScore | SJR | SNIP | CiteScore排名 | |||
|---|---|---|---|---|---|---|
| 6 | 1.424 | 1.328 | 学科类别 | 分区 | 排名 | 百分位 |
|
大类：大类：Medicine
小类：小类：Dermatology
|
Q1 | 17/142 | 88% | |||
| 按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：DERMATOLOGY | SCIE | Q1 | 20 / 94 | 79.3% |
| 按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：DERMATOLOGY | SCIE | Q1 | 19 / 94 | 80.32% |
文章名称
引用次数
Clinical Goals and Barriers to Effective Psoriasis Care
18
Secukinumab is Superior to Ustekinumab in Clearing Skin in Patients with Moderate to Severe Plaque Psoriasis (16-Week CLARITY Results)
14
Biosimilar Drugs for Psoriasis: Principles, Present, and Near Future
13
Nutraceuticals: A Review
13
Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab
13
The Role of Vitamins and Minerals in Hair Loss: A Review
11
Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test
11
Treatment of Atopic Dermatitis with Biologic Drugs
10
The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data Analysis
9
Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies
8
国家/地区
发文量
TUSA
108
TItaly
41
TSpain
28
TFrance
27
TGERMANY (FED REP GER)
26
TEngland
22
TCHINA MAINLAND
18
TPoland
18
TBelgium
14
TCanada
12
